Skip to main content

ETF comparison

FHLC vs XLV

Both Healthcare.

Fidelity MSCI Health Care Index ETF · State Street Health Care Select Sector SPDR ETF

Holdings overlap

Weighted by ISIN/CUSIP
85.0 %

60 positions appear in both funds. Buying equal dollars of FHLC and XLV would leave roughly 85.0% of each dollar exposed to the same underlying securities.

FHLC unmatched 14.8% Shared 85.0% XLV unmatched 14.7%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In FHLC only
274 positions
Shared
60 positions
In XLV only
0 positions

Side by side

FHLC

Fidelity MSCI Health Care Index ETF

Fidelity · Healthcare

79 composite / 100
Expense ratio
0.084%
Net assets
$3.54B
TTM yield
1.18%
Top-10 conc.
51.9%
XLV

State Street Health Care Select Sector SPDR ETF

State Street · Healthcare

82 composite / 100
Expense ratio
0.080%
Net assets
$43.39B
TTM yield
1.42%
Top-10 conc.
61.5%

Sub-score comparison

92
Cost
92
83
Tax efficiency
83
80
Liquidity
100
40
Concentration
26
—
Tracking quality
—
FHLC sub-score XLV

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

Expense ratios are effectively identical (0.084% vs 0.080%).

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with FHLC vs XLV.

Top shared holdings

60 shared in total
# Holding In FHLC In XLV Overlap
1 Eli Lilly & Co 13.35% 16.51% 13.35%
2 Johnson & Johnson 8.93% 10.64% 8.93%
3 AbbVie Inc 6.42% 7.74% 6.42%
4 UnitedHealth Group Inc 5.44% 6.57% 5.44%
5 Merck & Co Inc 4.66% 5.52% 4.66%
6 Thermo Fisher Scientific Inc 3.09% 3.24% 3.09%
7 Amgen Inc 3.00% 3.40% 3.00%
8 Abbott Laboratories 2.66% 2.75% 2.66%
9 Gilead Sciences Inc 2.34% 2.73% 2.34%
10 Pfizer Inc 2.06% 2.39% 2.06%
11 Bristol-Myers Squibb Co 1.93% 2.05% 1.93%
12 CVS Health Corp 1.92% 2.30% 1.92%

Only in FHLC

274 total
  • Natera Inc 0.52%
  • Illumina Inc 0.44%
  • Revolution Medicines Inc 0.44%
  • Alnylam Pharmaceuticals Inc 0.39%
  • Royalty Pharma PLC 0.35%
  • Tenet Healthcare Corp 0.32%
  • Insmed Inc 0.30%
  • United Therapeutics Corp 0.30%
  • Guardant Health Inc 0.28%
  • Neurocrine Biosciences Inc 0.23%

Only in XLV

0 total

Every XLV position is also held by FHLC.

Percentages are holdings overlap with the named fund.

Open FHLC or XLV at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.